Sharp Therapeutics (TSXV:SHRX) PB Ratio: (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:SHRX Sharp Therapeutics Corp TSXV:SHRX
15 GF Score
Price C$0.91
View Full Analysis

What is Sharp Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-26), Sharp Therapeutics's share price is C$0.91. Sharp Therapeutics's Book Value per Share for the quarter that ended in Dec. 2025 was C$-0.01. Hence, Sharp Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Sharp Therapeutics's PB Ratio or its related term are showing as below:

TSXV:SHRX's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.77
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Sharp Therapeutics's average Book Value Per Share Growth Rate was -106.10% per year.

Back to Basics: PB Ratio

Sharp Therapeutics  (TSXV:SHRX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Sharp Therapeutics PB Ratio Related Terms

Sharp Therapeutics PB Ratio Historical Data

* Premium members only.

The historical data trend for Sharp Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sharp Therapeutics PB Ratio Chart

Sharp Therapeutics Annual Data
Trend Dec23 Dec24 Dec25
PB Ratio
0.00 0.00 0.00

Sharp Therapeutics Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
PB Ratio Get a 7-Day Free Trial Premium Member Only 0.00 0.00 4.46 7.69 0.00

TSXV:SHRX vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, Sharp Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sharp Therapeutics PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sharp Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sharp Therapeutics's PB Ratio falls into.


TSXV:SHRX
15GF Score
Sharp Therapeutics Corp TSXV:SHRX
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sharp Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sharp Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=0.91/-0.008
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PB Ratio=Market Cap /(Total Stockholders Equity-Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Sharp Therapeutics Business Description

Address 2403 Sidney Street, Suite 264, Pittsburgh, PA, USA, 15203
Sharp Therapeutics Corp is a preclinical-stage drug discovery company developing therapeutics for genetic diseases. It has developed the patent-protected Disco discovery platform consisting of the CoreX biology, AlloChem chemistry, and Mine computational technologies to discover drugs that selectively activate the protein thats been altered by gene mutation. The company has targeted its discovery engine (Disco) to three hereditary disorders with high unmet need, which include Gauchers Disease, Familial Frontotemporal Dementia, and Niemann Pick Type-C. Its drug development pipeline consists of the following candidates: SEL-148, 721, SEL-148, 742, and SEL-145, 793. Geographically, the company's business operations are carried out in the United States of America.
15GF Score

Get the complete analysis for TSXV:SHRX

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.91
Price